focus -WSS

focus

author：focus 2025-09-06 10:59:16 - browse：1

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： New Medicare drug pricing powers could soon be upended in court

explore

WSS

The PBM ad wars are taking over Washington, D.C.

Neutralizing antibodies against HIV shows promise in children

Sen. Bill Cassidy on how to lower drug prices

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

North Korean leader's powerful sister says warplanes repelled US spy plane

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

knowledge

focus

focus

BioMarin wins approval for gene therapy to treat hemophilia A

DeSantis can now import cheaper drugs. But will Biden get credit?

Jerome Adams on the need for new antivirals for Covid

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Duchenne breakthrough therapy leaves behind pioneering families

Drinking water from half of US faucets contains PFAS: Study

Psychedelics group wrestles with new pharma identity

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Medicare proposal to cover medical devices draws a mixed reaction

Three issues to watch in global health in 2024

Wikipedia

The PBM ad wars are taking over Washington, D.C.

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Another man arrested in connection with shooting at Kansas nightclub

Idaho abortion case may prompt more restrictions in other states

Heart disease and mental health: A look at cardiac psychology

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

explore

explore

explore

focus